PO93 | Use of DOACS in heart transplantation recipients

Backgrounds and Aims: Direct Oral Anticoagulants (DOACs) are the treatment of choice for anticoagulation in patients with atrial fibrillation and venous thromboembolism. They have a superior efficacy and safety profile compared to Vitamin K Antagonists (VKAs), with less impact on the quality of lif...

Full description

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: PAGEPress Publications 2025-08-01
Series:Bleeding, Thrombosis and Vascular Biology
Subjects:
Online Access:https://www.btvb.org/btvb/article/view/363
Tags: Add Tag
No Tags, Be the first to tag this record!